Caredx Share Price Today
(NASDAQ: CDNA)

Name: Caredx Share Price Today (NASDAQ: CDNA) - Caredx Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Caredx share price is $20.42 & ₹1,777.87 as on 6 Mar 2025, 2.30 'hrs' IST

$20.42

▲

0.12

(0.59%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Caredx share price in Dollar and Rupees. Guide to invest in Caredx stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Caredx, along with analyst recommendations, forecasts, and comprehensive financials.

Caredx share price movements

Today's Low: $19.75
Today's High: $20.44
$20.42
3.28%
Downside
Day's Volatility :3.38%
Upside
0.1%
52 Weeks Low: $7.42
52 Weeks High: $34.84
$20.42
63.66%
Downside
52 Weeks Volatility :78.7%
Upside
41.39%

Caredx (CDNA) Returns

Period	Caredx, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-17.33%	3.7%	0.0%
6 Months	-24.73%	-2.8%	0.0%
1 Year	74.23%	2.5%	0.0%
3 Years	-36.43%	12.9%	-11.6%

Caredx (CDNA) Key Statistics

in dollars & INR

Previous Close	$20.3
Open	$20.31
Today's High	$20.44
Today's Low	$19.75
Market Capitalization	$1.1B
Today's Volume	$827.4K
52 Week High	$34.84
52 Week Low	$7.42
Revenue TTM	$333.8M
EBITDA	$-39.6M
Earnings Per Share (EPS)	$0.89
PE Ratio	22.81
Profit Margin	15.74%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	16.43%

How to invest in Caredx Stock (CDNA) from India?

It is very easy for Indian residents to invest directly in Caredx from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Caredx stock in both Indian Rupees (INR) and US Dollars (USD). Search for Caredx or CDNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Caredx or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Caredx shares which would translate to 0.043 fractional shares of Caredx as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Caredx, in just a few clicks!

Returns in Caredx (CDNA) for Indian investors in Rupees

The Caredx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Caredx investment value today

Current value as on today

₹1,79,297

Returns

₹79,297

(+79.3%)

Returns from Caredx Stock

₹74,232 (+74.23%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Caredx (CDNA)

-50%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Caredx Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Caredx

BlackRock Inc
9.48%
Vanguard Group Inc
9.06%
State Street Corp
4.96%
ARK Investment Management LLC
4.49%
BAMCO Inc
4.12%
Fred Alger Management, LLC
3.01%

Analyst Recommendation on Caredx

Buy

69%Buy

30%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Caredx(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Caredx Stock (CDNA)

What analysts predicted

Upside of 59.16%

Target:

$32.50

Current:

$20.42

Insights on Caredx Stock (Ticker Symbol: CDNA)

Price Movement
In the last 1 year, CDNA stock has moved up by 74.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 82.88M → 86.57M (in $), with an average increase of 4.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -7.40M → 87.69M (in $), with an average increase of 108.5% per quarter
CDNA vs TMO (3 yr)
In the last 3 years, Caredx, Inc. has experienced a drawdown of -39.8%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 35.6%

Caredx Technicals Summary

Sell

Neutral

Buy

Caredx is currently in a neutral trading position according to technical analysis indicators.

Caredx (CDNA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Caredx, Inc.	-11.6%	-24.73%	74.23%	-36.43%	-10.44%
Agilent Technologies Inc.	-13.96%	-8.56%	-13.48%	-2.94%	78.81%
Idexx Laboratories, Inc.	-5.98%	-6.81%	-21.57%	-15.48%	80.06%
Thermo Fisher Scientific, Inc.	-9.71%	-13.63%	-11.38%	-1.97%	77.48%
Danaher Corp.	-2.07%	-20.46%	-16.74%	-19.95%	48.71%
Iqvia Holdings Inc.	-7.09%	-25.1%	-26.53%	-14.22%	49.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Caredx, Inc.	22.81	22.81	-0.12	0.61	0.16	-0.07	NA	6.91
Agilent Technologies Inc.	29.02	29.02	2.0	5.57	0.21	0.08	0.01	21.13
Idexx Laboratories, Inc.	41.39	41.39	4.36	11.97	0.58	0.23	NA	19.55
Thermo Fisher Scientific, Inc.	31.65	31.65	2.02	23.33	0.13	0.05	0.0	130.22
Danaher Corp.	38.92	38.92	2.05	7.65	0.08	0.04	0.01	68.9
Iqvia Holdings Inc.	24.81	24.81	0.98	11.89	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Caredx, Inc.	Buy	$1.1B	-10.44%	22.81	15.74%
Agilent Technologies Inc.	Buy	$36.1B	78.81%	29.02	19.27%
Idexx Laboratories, Inc.	Buy	$35.9B	80.06%	41.39	22.78%
Thermo Fisher Scientific, Inc.	Buy	$194.9B	77.48%	31.65	14.77%
Danaher Corp.	Buy	$147.2B	48.71%	38.92	16.33%
Iqvia Holdings Inc.	Buy	$32.8B	49.88%	24.81	8.91%

About Caredx

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI, a transplant quality tracking software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Organization	Caredx
Employees	644
CEO	Mr. John Walter Hanna Jr.
Industry	Health Technology

Management People of Caredx

Name	Title
Mr. Abhishek Jain	CFO & Principal Accounting Officer
Dr. Peter Maag Ph.D.	Executive Director
Mr. John Walter Hanna Jr.	President, CEO & Director
Mr. Kashif Rathore	Chief Technology Officer
Dr. Robert N. Woodward Ph.D.	Chief Scientific Officer
Mr. Jeffrey A. Novack	General Counsel & Secretary
Ms. Stacey Follon	Senior VP & Head of Human Resources
Ms. Marica Grskovic Ph.D.	Chief Strategy Officer
Ms. Jessica Meng	Chief Commercial Officer
Ms. Jing Huang Ph.D.	Chief Data & Artificial Intelligence Officer

Important FAQs about investing in CDNA Stock from India :

What is Caredx share price today?

Caredx share price today stands at $20.42, Open: $20.31 ; Previous Close: $20.30 ; High: $20.44 ; Low: $19.75 ; 52 Week High: $34.84 ; 52 Week Low: $7.42.

The stock opens at $20.31, after a previous close of $20.30. The stock reached a daily high of $20.44 and a low of $19.75, with a 52-week high of $34.84 and a 52-week low of $7.42.

Can Indians buy Caredx shares?

Yes, Indians can invest in the Caredx (CDNA) from India.

With INDmoney, you can buy Caredx at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Caredx at zero transaction cost.

How can I buy Caredx shares from India?

It is very easy to buy Caredx from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Caredx (CDNA) be purchased?

Yes, you can buy fractional shares of Caredx with INDmoney app.

What are the documents required to start investing in Caredx stocks?

To start investing in Caredx, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.